Who Paid My Doc
Hymovis
Device Osteoarthritis
General payments
$274,608
Research payments
$754,897
Through program year 2025, $274,608 in general payments and $754,897 in research payments were reported against Hymovis (Osteoarthritis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $48,722 | 1,695 |
| 2024 | General | $34,615 | 1,636 |
| 2023 | General | $33,672 | 1,628 |
| 2022 | General | $37,898 | 1,920 |
| 2021 | General | $18,848 | 981 |
| 2020 | General | $23,013 | 1,315 |
| 2020 | Research | $188,508 | 26 |
| 2019 | General | $77,841 | 2,936 |
| 2019 | Research | $566,389 | 31 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 63 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
12,111 general · 57 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.